Xi Gu

692 total citations · 1 hit paper
21 papers, 407 citations indexed

About

Xi Gu is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Xi Gu has authored 21 papers receiving a total of 407 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 11 papers in Cancer Research and 7 papers in Molecular Biology. Recurrent topics in Xi Gu's work include Breast Cancer Treatment Studies (6 papers), MicroRNA in disease regulation (4 papers) and Cancer Cells and Metastasis (4 papers). Xi Gu is often cited by papers focused on Breast Cancer Treatment Studies (6 papers), MicroRNA in disease regulation (4 papers) and Cancer Cells and Metastasis (4 papers). Xi Gu collaborates with scholars based in China and United States. Xi Gu's co-authors include Jinqi Xue, Jiawen Bu, Yueting Hu, Yang Liu, Peng Qiu, Zhenyong Zhang, Jingying Li, Wenhai Zhang, Caigang Liu and Lisha Sun and has published in prestigious journals such as Annals of the New York Academy of Sciences, Annals of Oncology and Molecular Cancer.

In The Last Decade

Xi Gu

21 papers receiving 405 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Advances in immunotherapy for triple-negative breast cancer

2023 178 citations Yang Liu, Yueting Hu et al. Molecular Cancer profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xi Gu China	11	186	158	146	77	60	21	407
Raefa Abou Khouzam United Arab Emirates	12	201 1.1×	224 1.4×	179 1.2×	148 1.9×	87 1.4×	21	501
Kejin Wu China	14	204 1.1×	228 1.4×	199 1.4×	54 0.7×	91 1.5×	27	499
Jin-Zhi Xu China	9	205 1.1×	152 1.0×	225 1.5×	70 0.9×	72 1.2×	10	426
Qiaoru Guo China	8	241 1.3×	145 0.9×	131 0.9×	54 0.7×	58 1.0×	15	437
Elena Vagia United States	9	226 1.2×	153 1.0×	256 1.8×	82 1.1×	125 2.1×	25	493
Shi-Rong Zhang China	9	221 1.2×	150 0.9×	227 1.6×	71 0.9×	78 1.3×	11	441
Hui-Yen Chuang Taiwan	11	246 1.3×	159 1.0×	124 0.8×	109 1.4×	48 0.8×	18	466
Nick A. Kuburich United States	7	260 1.4×	117 0.7×	134 0.9×	51 0.7×	55 0.9×	14	443
Alessandra I. Riggio United Kingdom	6	228 1.2×	148 0.9×	232 1.6×	63 0.8×	84 1.4×	6	505
Zehua Wang China	13	275 1.5×	187 1.2×	185 1.3×	126 1.6×	103 1.7×	32	562

Countries citing papers authored by Xi Gu

Since Specialization

Citations

This map shows the geographic impact of Xi Gu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xi Gu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xi Gu more than expected).

Fields of papers citing papers by Xi Gu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xi Gu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xi Gu. The network helps show where Xi Gu may publish in the future.

Co-authorship network of co-authors of Xi Gu

This figure shows the co-authorship network connecting the top 25 collaborators of Xi Gu. A scholar is included among the top collaborators of Xi Gu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xi Gu. Xi Gu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zheng, Lifeng, et al.. (2024). Identification and validation of a prognostic signature based on six immune-related genes for colorectal cancer. Discover Oncology. 15(1). 192–192. 1 indexed citations

Qiu, Fang, Xi Gu, Xiaofeng Zheng, et al.. (2024). 276P SHR-A1811 in combination with pyrotinib as neoadjuvant treatment for HER2-positive breast cancer (HER2+ BC): Preliminary results from MUKDEN 07. Annals of Oncology. 35. S331–S331. 3 indexed citations

Chen, Guanglei, Lisha Sun, Xi Gu, et al.. (2023). FSIP1 enhances the therapeutic sensitivity to CDK4/6 inhibitors in triple-negative breast cancer patients by activating the Nanog pathway. Science China Life Sciences. 66(12). 2805–2817. 11 indexed citations

Gu, Xi, et al.. (2023). Modeling the Within-Host Dynamics of SARS-CoV-2 Infection Based on Antiviral Treatment. Mathematics. 11(16). 3485–3485. 3 indexed citations

Liu, Yang, Yueting Hu, Jinqi Xue, et al.. (2023). Advances in immunotherapy for triple-negative breast cancer. Molecular Cancer. 22(1). 145–145. 178 indexed citations breakdown →

Qiao, Xinbo, Yixiao Zhang, Lisha Sun, et al.. (2021). Association of human breast cancer CD44-/CD24- cells with delayed distant metastasis. eLife. 10. 24 indexed citations

Gu, Xi, et al.. (2021). Construction of competing endogenous RNA network and identification of novel molecular biomarkers in colon cancer. Medicine. 100(14). e25369–e25369. 6 indexed citations

Zhang, Yixiao, Xudong Zhu, Xinbo Qiao, et al.. (2020). LIPH promotes metastasis by enriching stem‐like cells in triple‐negative breast cancer. Journal of Cellular and Molecular Medicine. 24(16). 9125–9134. 19 indexed citations

Zhu, Xudong, Yang Bai, Xi Gu, et al.. (2020). HCK can serve as novel prognostic biomarker and therapeutic target for Breast Cancer patients. International Journal of Medical Sciences. 17(17). 2773–2789. 13 indexed citations

10.

Huang, Yong, et al.. (2020). The survival benefit of adjuvant radiotherapy for pathological T4N2M0 colon cancer in the Modern Chemotherapy Era: evidence from the SEER database 2004–2015. Artificial Cells Nanomedicine and Biotechnology. 48(1). 834–840. 7 indexed citations

11.

Liu, Chao, Xi Gu, Lisha Sun, et al.. (2019). Establishment and Verification of a Bagged-Trees-Based Model for Prediction of Sentinel Lymph Node Metastasis for Early Breast Cancer Patients. Frontiers in Oncology. 9. 282–282. 20 indexed citations

12.

Zhu, Xudong, Jinqi Xue, Xi Gu, et al.. (2019). Neoadjuvant Chemotherapy Plays an Adverse Role in the Prognosis of Grade 2 Breast Cancer. Journal of Cancer. 10(23). 5661–5670. 5 indexed citations

13.

Gu, Xi, Shuai Han, Meizi Cui, et al.. (2019). Knockdown of endothelin receptor B inhibits the progression of triple‐negative breast cancer. Annals of the New York Academy of Sciences. 1448(1). 5–18. 13 indexed citations

14.

Li, Jianyi, Jia Shi, Wenhai Zhang, et al.. (2015). Partial axillary lymph node dissection inferior to the intercostobrachial nerves complements sentinel node biopsy in patients with clinically node-negative breast cancer. BMC Surgery. 15(1). 79–79. 16 indexed citations

15.

Gu, Xi, et al.. (2015). Influence of MiR-451 on Drug Resistances of Paclitaxel-Resistant Breast Cancer Cell Line. Medical Science Monitor. 21. 3291–3297. 27 indexed citations

16.

Xue, Jinqi, Zhiguang Chen, Xi Gu, Yang Zhang, & Wenhai Zhang. (2015). MicroRNA-148a inhibits migration of breast cancer cells by targeting MMP-13. Tumor Biology. 37(2). 1581–1590. 32 indexed citations

17.

Gu, Xi, Yang Zhang, Long Chen, Jiao Guo, & Wenhai Zhang. (2014). Efficacy of neo-adjuvant chemotherapy with TEC regimen on breast cancer. Cancer Chemotherapy and Pharmacology. 75(2). 301–308. 4 indexed citations

18.

Li, Jianyi, Jia Shi, Wenhai Zhang, et al.. (2013). A New Technique That Complements Sentinel Lymph Node Biopsy: Lymph Node Dissection Under the Intercostobrachial Nerves in Early-Stage Breast Cancer. Clinical Breast Cancer. 13(3). 212–218. 4 indexed citations

19.

Li, Jianyi, Yang Zhang, Wenhai Zhang, et al.. (2013). Intercostobrachial Nerves as a Novel Anatomic Landmark for Dividing the Axillary Space in Lymph Node Dissection. ISRN Oncology. 2013. 1–7. 8 indexed citations

20.

He, Guijin, et al.. (2010). Effect of 103Pd radioactive stent on caspase-9, cholangiocarcinoma cell growth and its radiosensitivity. Surgical Oncology. 20(4). 247–251. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact